231 related articles for article (PubMed ID: 31043093)
1. Effect of Wellness Education on Quality of Life of Patients With Non-Small Cell Lung Cancer Treated With First-Line Icotinib and on Their Family Caregivers.
Li Y; Ling L; Zhanyu P
Integr Cancer Ther; 2019; 18():1534735419842373. PubMed ID: 31043093
[TBL] [Abstract][Full Text] [Related]
2. Influence of wellness education on first-line icotinib hydrochloride patients with stage IV non-small cell lung cancer and their family caregivers.
Yanwei L; Minghui F; Manman Q; Zhuchun Y; Dongying L; Zhanyu P
Curr Probl Cancer; 2018; 42(3):358-366. PubMed ID: 29731164
[TBL] [Abstract][Full Text] [Related]
3. Burden, emotional distress and quality of life among informal caregivers of lung cancer patients: An exploratory study.
Tan JY; Molassiotis A; Lloyd-Williams M; Yorke J
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28417550
[TBL] [Abstract][Full Text] [Related]
4. A double-edged sword: Should stage IV non-small cell lung cancer patients be informed of their cancer diagnosis?
Yanwei L; Dongying L; Zhuchen Y; Ling L; Yu Z; Zhanyu P
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28266089
[TBL] [Abstract][Full Text] [Related]
5. Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial.
Yang JJ; Zhou C; Huang Y; Feng J; Lu S; Song Y; Huang C; Wu G; Zhang L; Cheng Y; Hu C; Chen G; Zhang L; Liu X; Yan HH; Tan FL; Zhong W; Wu YL
Lancet Respir Med; 2017 Sep; 5(9):707-716. PubMed ID: 28734822
[TBL] [Abstract][Full Text] [Related]
6. [China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment (2015 version)].
Shi Y; Sun Y; Ding C; Wang Z; Wang C; Wang Z; Bai C; Bai C; Feng J; Liu X; Li F; Yang Y; Shu Y; Wu M; He J; Zhang Y; Zhang S; Chen G; Luo H; Luo R; Zhou C; Zhou Y; Pang Q; Zhao H; Zhao Q; Gu A; Ling Y; Huang C; Han B; Jiao S; Jian H
Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):397-400. PubMed ID: 26182862
[No Abstract] [Full Text] [Related]
7. Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial.
Shi Y; Zhang L; Liu X; Zhou C; Zhang L; Zhang S; Wang D; Li Q; Qin S; Hu C; Zhang Y; Chen J; Cheng Y; Feng J; Zhang H; Song Y; Wu YL; Xu N; Zhou J; Luo R; Bai C; Jin Y; Liu W; Wei Z; Tan F; Wang Y; Ding L; Dai H; Jiao S; Wang J; Liang L; Zhang W; Sun Y
Lancet Oncol; 2013 Sep; 14(10):953-61. PubMed ID: 23948351
[TBL] [Abstract][Full Text] [Related]
8. A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC).
Hu X; Han B; Gu A; Zhang Y; Jiao SC; Wang CL; He J; Jia X; Zhang L; Peng J; Wu M; Ying K; Wang J; Ma K; Zhang S; You C; Tan F; Wang Y; Ding L; Sun Y
Lung Cancer; 2014 Nov; 86(2):207-12. PubMed ID: 25261231
[TBL] [Abstract][Full Text] [Related]
9. Influence of preparedness on anxiety, depression, and quality of life in caregivers of heart failure patients: Testing a model of path analysis.
Petruzzo A; Biagioli V; Durante A; Emberti Gialloreti L; D'Agostino F; Alvaro R; Vellone E
Patient Educ Couns; 2019 May; 102(5):1021-1028. PubMed ID: 30611564
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of early combination of local radiotherapy and GM-CSF for advanced non-small cell lung cancer treated with icotinib.
Qiu Y; He X; Li Z; Jiang Y; Jia Y
Ir J Med Sci; 2020 Aug; 189(3):791-797. PubMed ID: 31797203
[TBL] [Abstract][Full Text] [Related]
11. The humanistic burden of advanced non-small cell lung cancer (NSCLC) in Europe: a real-world survey linking patient clinical factors to patient and caregiver burden.
Wood R; Taylor-Stokes G; Smith F; Chaib C
Qual Life Res; 2019 Jul; 28(7):1849-1861. PubMed ID: 30825160
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of icotinib in treating non-small cell lung cancer: a systematic evaluation and meta-analysis based on 15 studies.
Biaoxue R; Hua L; Wenlong G; Shuanying Y
Oncotarget; 2016 Dec; 7(52):86902-86913. PubMed ID: 27893423
[TBL] [Abstract][Full Text] [Related]
13. Family caregiver burden, skills preparedness, and quality of life in non-small cell lung cancer.
Grant M; Sun V; Fujinami R; Sidhu R; Otis-Green S; Juarez G; Klein L; Ferrell B
Oncol Nurs Forum; 2013 Jul; 40(4):337-46. PubMed ID: 23803267
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and influence factors of icotinib hydrochloride in treating advanced non-small cell lung cancer.
Ma XH; Tian TD; Liu HM; Li QJ; Gao QL; Li L; Shi B
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):266-274. PubMed ID: 28165562
[TBL] [Abstract][Full Text] [Related]
15. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.
Auchter RM; Scholtens D; Adak S; Wagner H; Cella DF; Mehta MP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1199-206. PubMed ID: 11483329
[TBL] [Abstract][Full Text] [Related]
16. Systematic Analysis of Icotinib Treatment for Patients with Non-Small Cell Lung Cancer.
Shi B; Zhang XB; Xu J; Huang XE
Asian Pac J Cancer Prev; 2015; 16(13):5521-4. PubMed ID: 26225704
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics, safety, and preliminary efficacy evaluation of icotinib in patients with advanced non-small cell lung cancer.
Liu D; Zhang L; Wu Y; Jiang J; Tan F; Wang Y; Liu Y; Hu P
Lung Cancer; 2015 Sep; 89(3):262-7. PubMed ID: 26162563
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of icotinib hydrochloride (BPI-2009H), an oral EGFR tyrosine kinase inhibitor, in patients with advanced NSCLC and other solid tumors.
Zhao Q; Shentu J; Xu N; Zhou J; Yang G; Yao Y; Tan F; Liu D; Wang Y; Zhou J
Lung Cancer; 2011 Aug; 73(2):195-202. PubMed ID: 21144613
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of gefitinib, icotinib, and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China.
Lu S; Ye M; Ding L; Tan F; Fu J; Wu B
Oncotarget; 2017 Feb; 8(6):9996-10006. PubMed ID: 28036283
[TBL] [Abstract][Full Text] [Related]
20. Family caregivers' distress levels related to quality of life, burden, and preparedness.
Fujinami R; Sun V; Zachariah F; Uman G; Grant M; Ferrell B
Psychooncology; 2015 Jan; 24(1):54-62. PubMed ID: 24789500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
